* Enfusion Inc ENFN.N ENFN.K is expected to show a rise
in
quarterly revenue when it reports results on May 9.
* The Chicago Illinois-based company is expected to report
a
22.4% increase in revenue to $41.79 million from $34.14 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Enfusion Inc is for
earnings of 3 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Enfusion
Inc is
$11.75, above its last closing price of $8.54.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.03 0.03 0.04 Beat 36.4
Sep. 30 2022 0.01 0.02 0.03 Beat 50
Jun. 30 2022 0.02 0.02 0.04 Beat 100
Mar. 31 2022 0.03 0.03 0.00 Missed -93.6
Dec. 0.03 0.04 0.02 Missed -43.6
31 2021
Sep. 30 2021 0.04 0.04 0.03 Missed -18.9
This summary was machine generated May 5 at 16:40 GMT. All
figures in US dollars unless otherwise stated